429 related articles for article (PubMed ID: 20637206)
1. T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner.
Uchida Y; Ke B; Freitas MC; Yagita H; Akiba H; Busuttil RW; Najafian N; Kupiec-Weglinski JW
Gastroenterology; 2010 Dec; 139(6):2195-206. PubMed ID: 20637206
[TBL] [Abstract][Full Text] [Related]
2. Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.
Liu Y; Ji H; Zhang Y; Shen X; Gao F; He X; Li GA; Busuttil RW; Kuchroo VK; Kupiec-Weglinski JW
J Hepatol; 2015 Mar; 62(3):563-72. PubMed ID: 25450716
[TBL] [Abstract][Full Text] [Related]
3. The emerging role of T cell immunoglobulin mucin-1 in the mechanism of liver ischemia and reperfusion injury in the mouse.
Uchida Y; Ke B; Freitas MC; Ji H; Zhao D; Benjamin ER; Najafian N; Yagita H; Akiba H; Busuttil RW; Kupiec-Weglinski JW
Hepatology; 2010 Apr; 51(4):1363-72. PubMed ID: 20091883
[TBL] [Abstract][Full Text] [Related]
4. Cross-regulation by TLR4 and T cell Ig mucin-3 determines severity of liver injury in a CCl4-induced mouse model.
Zhao L; Liang J; Rao W; Cui M; Ren S; Zhang L; Xu D; Han Q; Zang YJ; Zhang B
Scand J Immunol; 2020 Apr; 91(4):e12851. PubMed ID: 31733121
[TBL] [Abstract][Full Text] [Related]
5. Tim-3 exacerbates kidney ischaemia/reperfusion injury through the TLR-4/NF-κB signalling pathway and an NLR-C4 inflammasome activation.
Guo Y; Zhang J; Lai X; Chen M; Guo Y
Clin Exp Immunol; 2018 Jul; 193(1):113-129. PubMed ID: 29570768
[TBL] [Abstract][Full Text] [Related]
6. Viral interleukin-10 gene transfer prevents liver ischemia-reperfusion injury: Toll-like receptor-4 and heme oxygenase-1 signaling in innate and adaptive immunity.
Ke B; Shen XD; Tsuchihashi S; Gao F; Araujo JA; Busuttil RW; Ritter T; Kupiec-Weglinski JW
Hum Gene Ther; 2007 Apr; 18(4):355-66. PubMed ID: 17439357
[TBL] [Abstract][Full Text] [Related]
7. T-cell immunoglobulin and mucin domain 4 (TIM-4) signaling in innate immune-mediated liver ischemia-reperfusion injury.
Ji H; Liu Y; Zhang Y; Shen XD; Gao F; Busuttil RW; Kuchroo VK; Kupiec-Weglinski JW
Hepatology; 2014 Dec; 60(6):2052-2064. PubMed ID: 25066922
[TBL] [Abstract][Full Text] [Related]
8. The protective function of galectin-9 in liver ischemia and reperfusion injury in mice.
Hirao H; Uchida Y; Kadono K; Tanaka H; Niki T; Yamauchi A; Hata K; Watanabe T; Terajima H; Uemoto S
Liver Transpl; 2015 Jul; 21(7):969-81. PubMed ID: 25931247
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide PACAP in mouse liver ischemia and reperfusion injury: immunomodulation by the cAMP-PKA pathway.
Ji H; Zhang Y; Shen XD; Gao F; Huang CY; Abad C; Busuttil RW; Waschek JA; Kupiec-Weglinski JW
Hepatology; 2013 Mar; 57(3):1225-37. PubMed ID: 22532103
[TBL] [Abstract][Full Text] [Related]
10. Plasma membrane-bound G protein-coupled bile acid receptor attenuates liver ischemia/reperfusion injury via the inhibition of toll-like receptor 4 signaling in mice.
Yang H; Zhou H; Zhuang L; Auwerx J; Schoonjans K; Wang X; Feng C; Lu L
Liver Transpl; 2017 Jan; 23(1):63-74. PubMed ID: 27597295
[TBL] [Abstract][Full Text] [Related]
11. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
[TBL] [Abstract][Full Text] [Related]
12. ATF3-mediated NRF2/HO-1 signaling regulates TLR4 innate immune responses in mouse liver ischemia/reperfusion injury.
Rao J; Qian X; Li G; Pan X; Zhang C; Zhang F; Zhai Y; Wang X; Lu L
Am J Transplant; 2015 Jan; 15(1):76-87. PubMed ID: 25359217
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor erythroid 2-related factor 2 regulates toll-like receptor 4 innate responses in mouse liver ischemia-reperfusion injury through Akt-forkhead box protein O1 signaling network.
Huang J; Yue S; Ke B; Zhu J; Shen XD; Zhai Y; Yamamoto M; Busuttil RW; Kupiec-Weglinski JW
Transplantation; 2014 Oct; 98(7):721-8. PubMed ID: 25171655
[TBL] [Abstract][Full Text] [Related]
14. Negative CD4 + TIM-3 signaling confers resistance against cold preservation damage in mouse liver transplantation.
Liu Y; Ji H; Zhang Y; Shen XD; Gao F; Nguyen TT; Shang X; Lee N; Busuttil RW; Kupiec-Weglinski JW
Am J Transplant; 2015 Apr; 15(4):954-964. PubMed ID: 25676534
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury.
Shen XD; Ke B; Zhai Y; Gao F; Busuttil RW; Cheng G; Kupiec-Weglinski JW
Am J Transplant; 2005 Aug; 5(8):1793-800. PubMed ID: 15996225
[TBL] [Abstract][Full Text] [Related]
16. Gal-9/Tim-3 signaling pathway activation suppresses the generation of Th17 cells and promotes the induction of Foxp3
Wang Y; Feng T; Li H; Xiong Y; Tao Y
Mol Immunol; 2023 Apr; 156():136-147. PubMed ID: 36921488
[TBL] [Abstract][Full Text] [Related]
17. HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: regulation of TLR4 innate responses through PI3K/PTEN signaling.
Ke B; Shen XD; Ji H; Kamo N; Gao F; Freitas MC; Busuttil RW; Kupiec-Weglinski JW
J Hepatol; 2012 Feb; 56(2):359-66. PubMed ID: 21756853
[TBL] [Abstract][Full Text] [Related]
18. β-catenin regulates innate and adaptive immunity in mouse liver ischemia-reperfusion injury.
Ke B; Shen XD; Kamo N; Ji H; Yue S; Gao F; Busuttil RW; Kupiec-Weglinski JW
Hepatology; 2013 Mar; 57(3):1203-14. PubMed ID: 23081841
[TBL] [Abstract][Full Text] [Related]
19. Absence of toll-like receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model.
Shen XD; Ke B; Zhai Y; Gao F; Tsuchihashi S; Lassman CR; Busuttil RW; Kupiec-Weglinski JW
Liver Transpl; 2007 Oct; 13(10):1435-43. PubMed ID: 17902130
[TBL] [Abstract][Full Text] [Related]
20. CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury.
Shen X; Wang Y; Gao F; Ren F; Busuttil RW; Kupiec-Weglinski JW; Zhai Y
Hepatology; 2009 Nov; 50(5):1537-46. PubMed ID: 19670423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
